Found 6 matching trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
PHASE2A 2-night polysomnography / 5-way cross-over study to evaluate the effect, ...
Location
Central Arkansas Research
Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users
PHASE1This was a six-way crossover study with six single-dose treatment sessions....
Location
Multiple Locations
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
NAIn recent years, there has been increased focus on cognitive side effects o...
Location
San Francisco Veterans Affairs Medical Center
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
PHASE3A polysomnography study to evaluate the effect, safety and tolerability of ...
Location
Sleep Disorders Laboratory, Royal Adelaide Hospital
Almorexant in Primary Insomnia
PHASE1The aim of the study is to determine the minimum effective dose of ACT-0785...
Location
Medical University of Innsbruck, Dept. of Neurology Sleep Disorder Unit
Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206
PHASE1A study of ACT-462206 to evaluate the tolerability, safety, pharmacokinetic...
Location
Centre for Human Drug Research